£91.79

This is the most expensive it has ever been. Walk away.

£92 today · previous high £92 · all-time low £85

CRC Press Multiple Myeloma: Translational and Emerging Therapies (Translational Medicine)

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 74 days · 74 data points (no recent data)

Historical
Generating forecast…
£91.79 £84.04 £85.73 £87.42 £89.11 £90.80 £92.50 25 July 2026 12 August 2026 30 August 2026 17 September 2026 06 October 2026
View at Amazon ↗

Price data last checked 17 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 74 days • 2 price levels

Days at Price
Current Price
13 days 61 days · current 0 15 31 46 61 £85 £92 Days at Price

Price Analysis

Most common price: £92 (61 days, 82.4%)

Price range: £85 - £92

Price levels: 2 different prices over 74 days

Description
Multiple myeloma is the second most prevalent hematological malignancy, with over 55,000 new cases diagnosed each year. This exciting new text, edited by lauded authorities on the topic, stands as the only available reference to assemble, review, and synthesizes the latest studies on translational therapies and clearly explains the impact of molecular pathogenesis, biology, and prognostic factors on the diagnosis, prognosis, and individualization of treatment and the development of novel therapeutic options for patients with myeloma. Moving from the bench to the bedside to the forefront of therapeutic development, this source: helps clinicians and researchers effectively deploy therapeutic strategies into clinical practice reflects trends in the use of agents which target both the tumor cell and its bone marrow microenvironment to overcome resistance to conventional therapies considers the critical role of the bone marrow microenvironment in the regulation of growth, survival, and homing of multiple myeloma discusses novel therapies in phase I and phase II trials, focusing specifically on therapeutic options for patients with newly diagnosed or relapsed/refractory multiple myeloma addresses novel therapies for other plasma cell disorders, and provides the framework for the design of next generation agents and combination therapies covers the entire scope of translational work in multiple myeloma, from advances in molecular pathogenesis, to prognostic factors, immunotherapy, and new options for newly diagnosed and relapsed multiple myeloma patients

Product Specifications
Brand
CRC Press
Format
hardcover
ASIN
1420045105
Category
Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain
Amazon UK
Release Date
11 October 2007
Listed Since
05 January 2007

Barcode

No barcode data available

Similar Products You Might Like

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
98% match

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Springer

£80.67 24 Sep 2026
Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside
98% match

Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside

Elsevier

£167.99 22 Aug 2026
Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
97% match

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Springer

£103.09 12 Aug 2026
Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)
97% match

Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)

Springer

£99.39 11 Sep 2026
Treatment of Multiple Myeloma and Related Disorders
97% match

Treatment of Multiple Myeloma and Related Disorders

Cambridge University Press

£36.41 17 Sep 2026
Multiple Myeloma & Plasma Cell Neoplasms Clinical Guide
97% match

Multiple Myeloma & Plasma Cell Neoplasms Clinical Guide

Springer

£111.67 08 Oct 2026
Multiple Myeloma and Related Disorders (Hodder Arnold Publication)
97% match

Multiple Myeloma and Related Disorders (Hodder Arnold Publication)

CRC Press

£148.94 14 Aug 2026
Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)
97% match

Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)

Humana

£103.27 13 Aug 2026
Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)
97% match

Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)

Humana

£73.48 13 Oct 2026
Advances in Biology and Therapy of Multiple Myeloma Volume 2
97% match

Advances in Biology and Therapy of Multiple Myeloma Volume 2

Springer

£111.90 13 Oct 2026
Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)
97% match

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Springer

£100.11 12 Sep 2026
Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)
97% match

Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)

£92.80 25 Sep 2026
Clinical Malignant Hematology
97% match

Clinical Malignant Hematology

McGraw-Hill Education

£170.00 20 Aug 2026
Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)
97% match

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Springer

£100.11 04 Oct 2026
Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)
96% match

Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)

Springer

£144.43 20 Aug 2026
Horizons in Cancer Research. Volume 73: Volume 73
96% match

Horizons in Cancer Research. Volume 73: Volume 73

£112.65 15 Aug 2026
Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy)
96% match

Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy)

Springer

£83.26 09 Oct 2026
Multiple Myeloma: Methods and Protocols: 113 (Methods in Molecular Medicine, 113)
96% match

Multiple Myeloma: Methods and Protocols: 113 (Methods in Molecular Medicine, 113)

Humana

£61.58 23 Sep 2026
Consulting Hematology and Oncology Handbook
96% match

Consulting Hematology and Oncology Handbook

Springer

£59.97 23 Sep 2026
Hematologic Cancers: Molecular Pathobiology to Targeted Therapeutics
96% match

Hematologic Cancers: Molecular Pathobiology to Targeted Therapeutics

Springer

£113.76 03 Oct 2026
The International Consensus Classification of Myeloid and Lymphoid Neoplasms
96% match

The International Consensus Classification of Myeloid and Lymphoid Neoplasms

Lippincott Williams & Wilkins

£106.80 11 Sep 2026
Comprehensive Hematology and Stem Cell Research
96% match

Comprehensive Hematology and Stem Cell Research

Elsevier

£1,712.74 21 Aug 2026
Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders
96% match

Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders

Springer

£140.60 14 Aug 2026
Contemporary Management of Multiple Myeloma
96% match

Contemporary Management of Multiple Myeloma

Jaypee Brothers Medical Publishers

£39.79 22 Sep 2026